Overview

Warfarine in Unexplained Oligohydramnios

Status:
Terminated

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

This study examines using oral anti coagulant warfarin in the management of unexplained oligohydramnios improve the perinatal outcome with little or no complications to the mother or the neonates.

Phase:

Phase 4

Details

Lead Sponsor:

Woman's Health University Hospital, Egypt

Treatments:

Anticoagulants
Coagulants
Warfarin